shire.com
Shire Newsroom: Media, News & Press Releases
https://www.shire.com/newsroom
Annual and Interim Reports. Annual and Interim Reports. Excellence in ADHD Patient Group Awards 2016. RESEARCH AND EDUCATIONAL GRANTS. Thursday, September 1, 2016. Filter by: All Press Releases. Sort By: Most Recent. Sort By: A to Z. Sort By: Z to A. Head of Communications and Public Affairs. Communications and Public Affairs. Communications and Public Affairs. Communications and Public Affairs. For Marketed Product and Pipeline Inquiries. Communications and Public Affairs. For All International Inquiries.
investors.shire.com
Shire: E-communications
http://investors.shire.com/shareholder-information/e-communications.aspx
Skip to main content. Annual and Interim Reports. Annual and Interim Reports. Excellence in ADHD Patient Group Awards 2016. RESEARCH AND EDUCATIONAL GRANTS. Annual and Interim Reports. Shire proposed combination with Baxalta. Research and Development day. Annual and Interim Reports. Shire proposed combination with Baxalta. Research and Development day. Electronic and Printed Communications – Making Your Choice. To do this you must register free at http:/ www.shareview.co.uk. Shire's electronic communicat...
investors.shire.com
Shire: Financial Highlights
http://investors.shire.com/financial-highlights.aspx
Skip to main content. Annual and Interim Reports. Annual and Interim Reports. Excellence in ADHD Patient Group Awards 2016. RESEARCH AND EDUCATIONAL GRANTS. Annual and Interim Reports. Shire proposed combination with Baxalta. Research and Development day. Annual and Interim Reports. Shire proposed combination with Baxalta. Research and Development day. Non GAAP adjusted ROIC. Non GAAP cash generation. Non GAAP EBITDA margin. Non GAAP operating income. This is a Non GAAP financial measure. Learn more abou...
shire.com
About Shire: Business Development & Partnerships
https://www.shire.com/who-we-are/how-we-operate/partnerships
Annual and Interim Reports. Annual and Interim Reports. Excellence in ADHD Patient Group Awards 2016. RESEARCH AND EDUCATIONAL GRANTS. A CLEAR AND FOCUSED BUSINESS DEVELOPMENT STRATEGY. We are constantly seeking out new innovation opportunities through strategic partnerships, acquisitions and licenses. We strive to bolster our core therapeutic areas and expand into high-value adjacent therapeutic areas to create the most value for our patients, partners and Shire. WHY PARTNER WITH SHIRE? By following thi...
shire.com
Shire: Our Leadership
https://www.shire.com/who-we-are/leadership
Annual and Interim Reports. Annual and Interim Reports. Excellence in ADHD Patient Group Awards 2016. RESEARCH AND EDUCATIONAL GRANTS. Effective leadership is integral to the execution of Shire's strategy and therefore to the fulfillment of its objectives. Our leaders drive the vision of transforming the lives of people whose health is impacted by rare and other specialist conditions through innovative treatments. Our leadership includes the Board of Directors and the Executive Committee. The site uses c...
shire.com
About Shire: Our Culture
https://www.shire.com/who-we-are/our-story/our-culture
Annual and Interim Reports. Annual and Interim Reports. Excellence in ADHD Patient Group Awards 2016. RESEARCH AND EDUCATIONAL GRANTS. We are committed to recruit, develop and retain top talent who take a responsible and ethical approach to all that we do and who want to make a difference in the lives of patients across the globe. Read the Responsibility Review. Learn more about our approach to Responsibility, 2015 achievements and goals for 2016. Sign Up for Email or SMS Alerts.
shire.com
Shire: Our Approach to Responsibility
https://www.shire.com/who-we-are/responsibility/our-approach
Annual and Interim Reports. Annual and Interim Reports. Excellence in ADHD Patient Group Awards 2016. RESEARCH AND EDUCATIONAL GRANTS. Our Policies and Positions. Responsibility has always been embedded in our business – we have never separated it from our daily activities, decisions, and relationships. Meeting ever-changing stakeholder expectations and anticipating emerging risks, issues, and opportunities continues to be integral to our approach to operating an ethical and responsible business. Our pri...
investors.shire.com
Shire: Annual and Interim Reports 2015
http://investors.shire.com/annual-and-interim-reports/year-2015.aspx
Skip to main content. Annual and Interim Reports. Annual and Interim Reports. Excellence in ADHD Patient Group Awards 2016. RESEARCH AND EDUCATIONAL GRANTS. Annual and Interim Reports. Shire proposed combination with Baxalta. Research and Development day. Annual and Interim Reports. Shire proposed combination with Baxalta. Research and Development day. Annual and Interim Reports. Annual and Interim Reports. Aug 05, 2016. Jul 30, 2015. Mar 26, 2015. Annual Report for the year ended December 31, 2014.
shire.com
About Shire: Transparency Disclosures
https://www.shire.com/who-we-are/how-we-operate/transparency-disclosures
Annual and Interim Reports. Annual and Interim Reports. Excellence in ADHD Patient Group Awards 2016. RESEARCH AND EDUCATIONAL GRANTS. In keeping with our commitment to ensure responsible business practices, Shire believes transparency in our funding decisions is vital to building and maintaining trust with our stakeholders. We support patient organizations in our therapeutic areas through sponsorships, grants and donations. Shire makes charitable donations (to include both cash and in-kind giving) to lo...
shire.co.kr
Shire 정보: 당사 이력
http://www.shire.co.kr/who-we-are/our-story/our-history
환우 단체 지원 정보. 연구 및 교육 지원. Shire의 역사는 소규모 기업들이 당시 충족되지 못한 의료 요구에 대한 해결책을 강구하던 1986년으로 거슬러 올라갑니다. 초기 2년의 운영기간 동안 당사는 골다공증을 치료하고 예방하기 위해 다양한 칼슘보충제를 판매 시작하였습니다. 이후 알츠하이머병 및 말기 신부전과 같은 험난한 질환을 직면한 환자들을 위한 혁신적인 약물개발을 위한 프로그램을 진행하였습니다. 2016년 6월, Shire는 Baxalta와의 합병을 통해 희귀질환 및 특수한 질환으로 고통 받는 이들을 위한 일에 초점을 맞춘 선도적인 글로벌 생명공학 기업으로 거듭났습니다. 전세계 100여국의 22,000여명의 Shire 직원들은 충족되지 못한 의료 요구를 가진 환자들을 돕고자 Shire의 영향력을 확대 시키고 최고 수준의 제품을 공급하기 위해 노력하고 있습니다. 지속 가능한 100대 글로벌 기업에 선정된 Shire. Email 또는 SMS 알림 수신 서명.
